<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glaucoma</journal-id><journal-title-group><journal-title xml:lang="ru">Национальный журнал Глаукома</journal-title><trans-title-group xml:lang="en"><trans-title>National Journal glaucoma</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-4104</issn><issn pub-type="epub">2311-6862</issn><publisher><publisher-name>Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53432/2078-4104-2022-21-4-3-12</article-id><article-id custom-type="elpub" pub-id-type="custom">glaucoma-411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Корреляционный анализ морфофункциональных и иммунологических параметров у пациентов с продвинутыми стадиями первичной открытоугольной глаукомы</article-title><trans-title-group xml:lang="en"><trans-title>Correlation analysis of morphofunctional and immunological parameters in patients with advanced stages of primary open-angle glaucoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4675-9648</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котелин</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotelin</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Котелин Владислав Игоревич - научный сотрудник отдела клинической физиологии зрения им. С.В. Кравкова.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Researcher at the Department of Clinical Physiology of Vision named after S.V. Kravkov.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">vladislavkotelin@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0161-5010</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зуева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zueva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор биологических наук, профессор, начальник отдела клинической физиологии зрения им. С.В. Кравкова.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Dr. Sci. (Biol.), Professor, Head of the Department of Clinical Physiology of Vision named after S.V. Kravkov.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8007-6643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балацкая</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Balatskaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, начальник отдела иммунологии и вирусологии.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.), Head of the Department of Immunology and Virology.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6922-0464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, начальник отдела глаукомы.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Head of the Glaucoma Department.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8381-2124</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, научный сотрудник отдела глаукомы.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Researcher at the Glaucoma Department.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0148-8517</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цапенко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsapenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, главный специалист отдела клинической физиологии зрения им. С.В. Кравкова.</p><p>105062, Москва, ул. Садовая-Черногрязская, 14/19</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.), Chief Specialist of the Department of Clinical Physiology of Vision named after S.V. Kravkov.</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр глазных болезней им. Гельмгольца Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2022</year></pub-date><volume>21</volume><issue>4</issue><fpage>3</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Котелин В.И., Зуева М.В., Балацкая Н.В., Петров С.Ю., Журавлева А.Н., Цапенко И.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Котелин В.И., Зуева М.В., Балацкая Н.В., Петров С.Ю., Журавлева А.Н., Цапенко И.В.</copyright-holder><copyright-holder xml:lang="en">Kotelin V.I., Zueva M.V., Balatskaya N.V., Petrov S.Y., Zhuravleva A.N., Tsapenko I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.glaucomajournal.ru/jour/article/view/411">https://www.glaucomajournal.ru/jour/article/view/411</self-uri><abstract><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Изучить корреляционные взаимосвязи между данными иммунологических исследований и показателей электроретинографии (ЭРГ) и оптической когерентной томографии (ОКТ) у пациентов с продвинутыми стадиями первичной открытоугольной глаукомой (ПОУГ).</p></sec><sec><title>МЕТОДЫ</title><p>МЕТОДЫ. Ранее нами было выполнено мультимодальное исследование пациентов с продвинутыми стадиями глаукомы, включающее электроретинографию, морфометрические и иммунологические исследования. В настоящей работе проведен корреляционный анализ данных иммунологических и морфофункциональных исследований у больных с продвинутыми стадиями ПОУГ. Проанализированы результаты исследований 35 пациентов (35 глаз), в том числе 19 женщин и 16 мужчин, в двух группах: 1 — с развитой (12 больных, 12 глаз), и 2 — далекозашедшей стадией ПОУГ (23 пациента, 23 глаза). Средний возраст исследуемых составил 64,2±6,5 лет. Внутриглазное давление было компенсировано у всех обследуемых. Для вычисления линейной зависимости между непрерывными признаками использовали коэффициент корреляции Пирсона.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. В подгруппе с развитой глаукомой выявлены достоверные корреляции «заметной» силы (по шкале Чеддока) между параметрами паттерн-ЭРГ (ПЭРГ) и фотопического негативного ответа (ФНО) и уровнем VEGF-A в сыворотке крови (СК), EGF в слезной жидкости (СЖ) и внутриглазной жидкости (ВГЖ); и взаимосвязи «высокой» силы – для концентраций EGF и TGF-β2 в ВГЖ. В группе больных с далекозашедшей ПОУГ выявлены корреляции «умеренной» силы для параметров ПЭРГ и ФНО и содержания IL-1RA в СЖ, и «заметная» корреляция экспрессии TGF-β2 в ВГЖ с амплитудой ФНО от изолинии. У пациентов со развитой стадией глаукомы уровни содержания MIP-1β/CCL4 в СЖ, IL-1RA в ВГЖ коррелируют с толщиной слоя нервных волокон сетчатки (СНВС) и ганглиозных клеток сетчатки (ГКС), а концентрации EGF в СЖ и ВГЖ — с толщиной СНВС. В группе с далекозашедшей ПОУГ обнаружены корреляции «умеренной» силы для уровня экспрессии TNF-α, IL-8/CXCL8 в СЖ и толщины СНВС и «заметной» силы — для содержания  IP-10/CXCL10,  HGF/SF,  TGF-β2  в  ВГЖ  и  толщины СНВС и слоя ГКС.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Сопоставление результатов электроретинографии, ОКТ и уровня цитокинов разнообразного биологического действия в СК, СЖ и ВГЖ подтверждают клинически значимую информативность параметров ПЭРГ и ФНО и показателей иммунологических исследований как маркеров продвинутых стадий ПОУГ и позволяют выделить EGF в качестве наиболее перспективного патогенетически ориентированного иммунологического маркера II и III стадии глаукомы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>PURPOSE</title><p>PURPOSE. To study the correlations between the immunological data and the indicators of electroretinography (ERG) and optical coherence tomography (OCT) in patients with advanced stages of primary open-angle glaucoma (POAG).</p></sec><sec><title>METHODS</title><p>METHODS. Previously, we conducted a multimodal study of patients with advanced stages of glaucoma involving ERG, morphometric and immunological studies. In this new study we performed a correlation analysis of the immunological and morphofunctional data of patients with advanced stages of POAG. The study included 35 patients (35 eyes), among them 19 women and 16 men, who were divided into two groups: group 1 — stage II POAG (12 patients, 12 eyes), and group 2 — stage III POAG (23 patients, 23 eyes). The average age of the subjects was 64.2±6.5 years. Intraocular pressure was compensated in all study patients. The Pearson's correlation coefficient was used to calculate the linear relationship between continuous features.</p></sec><sec><title>RESULTS</title><p>RESULTS. In the subgroup with stage II POAG significant correlations of moderate strength (according to the Chaddock scale) were found between the parameters of pattern ERG (PERG) and photopic negative response (PhNR) and the level of VEGF-A in the blood serum (BS), EGF in the tear fluid (TF) and aqueous humor (AH); strong correlations — for the concentrations of EGF and TGF-β2 in the AH. In group 2, moderate correlations between PERG and PhNR parameters and the level of IL-1RA in the TF were found, as well as moderate correlation of TGF-β2 expression in the AH with PnHR amplitude from the baseline. In patients with stage II glaucoma, the levels of MIP-1β/CCL4 in the TF, IL-1RA in the intraocular fluid correlated with the thickness of the retinal nerve fiber layer (RNFL) and retinal ganglion cell layer (GCL), while the EGF in the TF and AH correlated with RNFL thickness. In the group with stage III POAG, correlations of moderate strength were found for the expression level of TNF-α, IL-8/CXCL8 in the TF and RNFL thickness, and strong correlations — for the level of IP-10/CXCL10, HGF/SF, TGF-β2 in AH and the thickness of RNFL and GCL.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION. Comparison of ERG, OCT findings and the level of cytokines of various biological effects in the BS, TF and AH confirmed the high informativeness of PERG and PhNR indicators and immunological data as markers of advanced stages of POAG, and allow EGF to be considered as the most promising pathogenetically oriented immunological marker of II and III stages of glaucoma.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>электроретинография</kwd><kwd>оптическая когерентная томография</kwd><kwd>иммунологические исследования</kwd><kwd>продвинутые стадии первичной открытоугольной глаукомы</kwd><kwd>цитокины</kwd><kwd>нейровоспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>electroretinography</kwd><kwd>optical coherence tomography</kwd><kwd>immunological studies</kwd><kwd>advanced stages of primary open-angle glaucoma</kwd><kwd>cytokines</kwd><kwd>neuroinflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tham Y.C., Li X., Wong T.Y., Quigley, H. A. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121(11):2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013</mixed-citation><mixed-citation xml:lang="en">Tham Y.C., Li X., Wong T.Y., Quigley, H. A. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121(11):2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева М.В. Динамика гибели ганглиозных клеток сетчатки при глаукоме и ее функциональные маркеры. Национальный журнал глаукома 2016; 15(1):70-85.</mixed-citation><mixed-citation xml:lang="en">Zueva M.V. Dynamics of retinal ganglion cell death in glaucoma and its functional markers. Natsional’nyi zhurnal glaukoma 2016; 15(1): 70-85.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal R., Gupta S.K., Agarwal P., Saxena R. et al. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol 2009; 57(4):257-266. https://doi.org/10.4103/0301-4738.53049</mixed-citation><mixed-citation xml:lang="en">Agarwal R., Gupta S.K., Agarwal P., Saxena R. et al. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol 2009; 57(4):257-266. https://doi.org/10.4103/0301-4738.53049</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kaushik S., Pandav S.S., Ram J. Neuroprotection in glaucoma. J Postgrad Med 2003;49(1):90-95. https://doi.org/10.4103/0022-3859.917</mixed-citation><mixed-citation xml:lang="en">Kaushik S., Pandav S.S., Ram J. Neuroprotection in glaucoma. J Postgrad Med 2003;49(1):90-95. https://doi.org/10.4103/0022-3859.917</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Иомдина Е.Н., Киселева О.А., Назаренко Л.А., Игнатьева Н.Ю., Баграташвили В.Н. Влияние биомеханических свойств корнеосклеральной капсулы глаза на гидродинамику внутриглазной жидкости. Биомедицина 2012; 1(3):25-30.</mixed-citation><mixed-citation xml:lang="en">Iomdina E.N., Kiseleva O.A., Nazarenko L.A., Ignatieva N.Yu., Bagratashvili V.N. The impact of biomechanical properties of the corneoscleral shell on eye hydrodynamics (an experimental study). Journal Biomed 2012; 1(3):25-30.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Flammer J., Haefliger I.O., Orgul S., Resink T. et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 1999; 8(3):212-219.</mixed-citation><mixed-citation xml:lang="en">Flammer J., Haefliger I.O., Orgul S., Resink T. et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 1999; 8(3):212-219.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wiggs J.L., Pasquale L.R. Genetics of glaucoma. Hum Mol Genet 2017; 26(R1):R21-R27. https://doi.org/10.1093/hmg/ddx184</mixed-citation><mixed-citation xml:lang="en">Wiggs J.L., Pasquale L.R. Genetics of glaucoma. Hum Mol Genet 2017; 26(R1):R21-R27. https://doi.org/10.1093/hmg/ddx184</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wei X., Cho K.S., Thee E.F., Jager M.J. et al. Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res 2019; 97(1):70-76. https://doi.org/10.1002/jnr.24256</mixed-citation><mixed-citation xml:lang="en">Wei X., Cho K.S., Thee E.F., Jager M.J. et al. Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res 2019; 97(1):70-76. https://doi.org/10.1002/jnr.24256</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vidal-Villegas B., Burgos-Blasco B., Santiago Alvarez J.L., Espino-Paisan L. et al. Proinflammatory cytokine profile differences between primary open-angle and pseudoexfoliative glaucoma. Ophthalmic Res 2022; 65(1):111-120. https://doi.org/10.1159/000519816</mixed-citation><mixed-citation xml:lang="en">Vidal-Villegas B., Burgos-Blasco B., Santiago Alvarez J.L., Espino-Paisan L. et al. Proinflammatory cytokine profile differences between primary open-angle and pseudoexfoliative glaucoma. Ophthalmic Res 2022; 65(1):111-120. https://doi.org/10.1159/000519816</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kokubun T., Tsuda S., Kunikata H., Yasuda M. et al. Characteristic profiles of inflammatory cytokines in the aqueous humor of glaucomatous eyes. Ocul Immunol Inflamm 2018; 26(8):1177-1188. https://doi.org/10.1080/09273948.2017.1327605</mixed-citation><mixed-citation xml:lang="en">Kokubun T., Tsuda S., Kunikata H., Yasuda M. et al. Characteristic profiles of inflammatory cytokines in the aqueous humor of glaucomatous eyes. Ocul Immunol Inflamm 2018; 26(8):1177-1188. https://doi.org/10.1080/09273948.2017.1327605</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Слепова О.С., Арапиев М.У., Ловпаче Д.Н., Балацкая Н.В., Куликова И.Г. Особенности местного и системного цитокинового статуса у здоровых разного возраста и пациентов с начальной стадией первичной открытоугольной глаукомы. Национальный журнал глаукома 2016; 15(1):3-12. https://doi.org/10.1097/00004647-199605000-00004</mixed-citation><mixed-citation xml:lang="en">Slepova O.S., Arapiev M.U., Lovpache D.N., Balatskaya N.V., Kulikova I.G. Specifics of local and systemic cytokine profile in healthy people of different ages and patients with early stage of primary open-angle glaucoma. Natsional’nyi zhurnal glaukoma 2016; 15(1): 3-12. https://doi.org/10.1097/00004647-199605000-00004</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Балацкая Н. В., Петров С. Ю., Котелин В. И., Куликова И.Г. Локальная и системная продукция 47 цитокинов у пациентов с продвинутыми стадиями первичной открытоугольной глаукомы. Современные проблемы науки и образования 2021; 3. https://doi.org/10.17513/spno.30906</mixed-citation><mixed-citation xml:lang="en">Balatskaya N.V., Petrov S.Yu., Kotelin V.I., Kulikova I.G. Local and systemic production of 47 cytokines in patients with advanced openangle glaucoma. Modern Problems of Science and Education. Surgery. 2021; 3. https://doi.org/10.17513/spno.30906</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллова М.О., Журавлева А.Н., Зуева М.В., Цапенко И.В. Структурно-функциональные корреляции в препериметрической и начальной стадиях глаукомной оптической нейропатии. Российский офтальмологический журнал 2021; 14(2):14-22. https://doi.org/10.21516/2072-0076-2021-14-2-14-22.</mixed-citation><mixed-citation xml:lang="en">Kirillova M.O., Zhuravleva A.N., Zueva M.V., Tsapenko I.V. Structural and functional correlations in the pre-perimetric and the initial stages of glaucomatous optic neuropathy. Russian Ophthalmological Journal 2021; 14(2):14-22. https://doi.org/10.21516/2072-0076-2021-14-2-14-22.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Котелин В.И., Зуева М.В., Цапенко И.В., Петров С.Ю., Журавлева А.Н. Электрофизиологические маркеры развитых стадий глаукомной оптической нейропатии. Российский офтальмологический журнал 2021; 14(3):19-24. https://doi.org/10.21516/2072-0076-2021-14-3-19-24</mixed-citation><mixed-citation xml:lang="en">Kotelin V.I., Zueva M.V., Tsapenko I.V., Petrov S.Yu., Zhuravleva A.N. Electrophysiological markers of advanced stages of glaucomatous optic neuropathy. Russian Ophthalmological Journal 2021; 14(3): 19-24. https://doi.org/10.21516/2072-0076-2021-14-3-19-24</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Котелин В.И., Петров С.Ю., Журавлева А.И., Зуева М.В., Цапенко И.В. Структурно-функциональные корреляции у пациентов с продвинутыми стадиями первичной открытоугольной глаукомы. Офтальмология 2021; 18(2):266-275. https://doi.org/10.18008/1816-5095-2021-2-266-275</mixed-citation><mixed-citation xml:lang="en">Kotelin V.I., Petrov S.Yu., Zhuravleva A.N., Zueva M.V., Tsapenko I.V. Structural and Functional Correlations in Patients with Advanced Stages of Primary Open-Angle Glaucoma. Ophthalmology in Russia 2021; 18(2):266-275. https://doi.org/10.18008/1816-5095-2021-2-266-275</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Егоров Е.А. Глаукома. Национальное руководство. Москва: ГЭО-ТАР-Медиа 2014; 824.</mixed-citation><mixed-citation xml:lang="en">Egorov E.A. Glaukoma. Nacional'noe rukovodstvo [Glaucoma. National guidelines]. Moscow, GEOTAR-Media Publ., 2014. 824 p.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Burgos-Blasco B., Vidal-Villegas B., Saenz-Frances F., Morales-Fernandez L. et al. Tear and aqueous humour cytokine profile in primary open-angle glaucoma. Acta Ophthalmol 2020; 98(6):e768-e772. https://doi.org/10.1111/aos.14374</mixed-citation><mixed-citation xml:lang="en">Burgos-Blasco B., Vidal-Villegas B., Saenz-Frances F., Morales-Fernandez L. et al. Tear and aqueous humour cytokine profile in primary open-angle glaucoma. Acta Ophthalmol 2020; 98(6):e768-e772. https://doi.org/10.1111/aos.14374</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Park D.Y., Kim M., Cha S.C. Cytokine and Growth Factor Analysis in Exfoliation Syndrome and Glaucoma. Invest Ophthalmol Vis Sci 2021; 62(15):6. https://doi.org/10.1167/iovs.62.15.6</mixed-citation><mixed-citation xml:lang="en">Park D.Y., Kim M., Cha S.C. Cytokine and Growth Factor Analysis in Exfoliation Syndrome and Glaucoma. Invest Ophthalmol Vis Sci 2021; 62(15):6. https://doi.org/10.1167/iovs.62.15.6</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ebneter A., Casson R. J., Wood J. P., Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Investigative ophthalmology &amp; visual science 2020; 51(12):6448-6460. https://doi.org/10.1167/iovs.10-5284</mixed-citation><mixed-citation xml:lang="en">Ebneter A., Casson R. J., Wood J. P., Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Investigative ophthalmology &amp; visual science 2020; 51(12):6448-6460. https://doi.org/10.1167/iovs.10-5284</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Margeta M.A., Lad E.M., Proia A.D. CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma. Graefes Arch Clin Exp Ophthalmol 2018; 256(12):449-2456. https://doi.org/10.1007/s00417-018-4081-y</mixed-citation><mixed-citation xml:lang="en">Margeta M.A., Lad E.M., Proia A.D. CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma. Graefes Arch Clin Exp Ophthalmol 2018; 256(12):449-2456. https://doi.org/10.1007/s00417-018-4081-y</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jacques C., Gosset M., Berenbaum F., Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm 2006; 74:371-403. https://doi.org/10.1016/S0083-6729(06)74016-X.</mixed-citation><mixed-citation xml:lang="en">Jacques C., Gosset M., Berenbaum F., Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm 2006; 74:371-403. https://doi.org/10.1016/S0083-6729(06)74016-X.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tezel G., Wax M.B. Increased production of tumor necrosis factoralpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20(23):8693-8700. https://doi.org/10.1523/JNEUROSCI.20-23-08693.2000</mixed-citation><mixed-citation xml:lang="en">Tezel G., Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20(23):8693-8700. https://doi.org/10.1523/JNEUROSCI.20-23-08693.2000</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci 2004; 45(11):4049-4059. https://doi.org/10.1167/iovs.04-0490</mixed-citation><mixed-citation xml:lang="en">Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci 2004; 45(11):4049-4059. https://doi.org/10.1167/iovs.04-0490</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J.J., Williams W., Wang B., Wei J. et al. Cytotoxic effect of inter-leukin-8 in retinal ganglion cells and its possible mechanisms. Int J Ophthalmol 2018; 11(8):1277-1283. https://doi.org/10.18240/ijo.2018.08.05</mixed-citation><mixed-citation xml:lang="en">Wang J.J., Williams W., Wang B., Wei J. et al. Cytotoxic effect of inter-leukin-8 in retinal ganglion cells and its possible mechanisms. Int J Ophthalmol 2018; 11(8):1277-1283. https://doi.org/10.18240/ijo.2018.08.05</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ha Y., Liu H., Xu Z., Yokota H. et al. Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma. Cell Death Dis 2015; 6:e1900. https://doi.org/10.1038/cddis.2015.281.</mixed-citation><mixed-citation xml:lang="en">Ha Y., Liu H., Xu Z., Yokota H. et al. Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma. Cell Death Dis 2015; 6:e1900. https://doi.org/10.1038/cddis.2015.281.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">He X., Li M. The expression of EGF mRNA and EGF receptors in human trabecular meshwork cells in vitro. Zhonghua Yan Ke Za Zhi 1997; 33(6):406-409.</mixed-citation><mixed-citation xml:lang="en">He X., Li M. The expression of EGF mRNA and EGF receptors in human trabecular meshwork cells in vitro. Zhonghua Yan Ke Za Zhi 1997; 33(6):406-409.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Weidner K.M., Hartmann G., Naldini L., Comoglio P.M. Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS 1993; 65:311-328.</mixed-citation><mixed-citation xml:lang="en">Weidner K.M., Hartmann G., Naldini L., Comoglio P.M. Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS 1993; 65:311-328.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Foxton R.H., Finkelstein A., Vijay S., Dahlmann-Noor A. et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. Am J Pathol 2013; 182(4):1379-1390. https://doi.org/10.1016/j.ajpath.2012.12.032</mixed-citation><mixed-citation xml:lang="en">Foxton R.H., Finkelstein A., Vijay S., Dahlmann-Noor A. et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. Am J Pathol 2013; 182(4):1379-1390. https://doi.org/10.1016/j.ajpath.2012.12.032</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Nishijima K., Ng Y.S., Zhong L., Bradley J. et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171(1):53-67. https://doi.org/10.1016/j.ajpath.2012.12.032</mixed-citation><mixed-citation xml:lang="en">Nishijima K., Ng Y.S., Zhong L., Bradley J. et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171(1):53-67. https://doi.org/10.1016/j.ajpath.2012.12.032</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mackenzie F., Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development 2012; 139(8):1371-1380. https://doi.org/10.2353/ajpath.2007.061237</mixed-citation><mixed-citation xml:lang="en">Mackenzie F., Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development 2012; 139(8):1371-1380. https://doi.org/10.2353/ajpath.2007.061237</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Fuchshofer R. The pathogenic role of transforming growth factor-beta2 in glaucomatous damage to the optic nerve head. Exp Eye Res 2011; 93(2):165-169. https://doi.org/10.1016/j.exer.2010.07.014</mixed-citation><mixed-citation xml:lang="en">Fuchshofer R. The pathogenic role of transforming growth factor-beta2 in glaucomatous damage to the optic nerve head. Exp Eye Res 2011; 93(2):165-169. https://doi.org/10.1016/j.exer.2010.07.014</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Prendes M.A., Harris A., Wirostko B.M., Gerber A.L. et al. The role of transforming growth factor beta in glaucoma and the therapeutic implications. Br J Ophthalmol 2013;97(6):680-686. https://doi.org/10.1136/bjophthalmol-2011-301132.</mixed-citation><mixed-citation xml:lang="en">Prendes M.A., Harris A., Wirostko B.M., Gerber A.L. et al. The role of transforming growth factor beta in glaucoma and the therapeutic implications. Br J Ophthalmol 2013;97(6):680-686. https://doi.org/10.1136/bjophthalmol-2011-301132.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wordinger R.J., Sharma T., Clark A.F. The role of TGF-beta2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J Ocul Pharmacol Ther 2014; 30(2-3):154-162. https://doi.org/10.1089/jop.2013.0220</mixed-citation><mixed-citation xml:lang="en">Wordinger R.J., Sharma T., Clark A.F. The role of TGF-beta2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J Ocul Pharmacol Ther 2014; 30(2-3):154-162. https://doi.org/10.1089/jop.2013.0220</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
